Loading…
Stereotaxis has struck a deal to buy Access Point Technologies (APT) for an undisclosed sum, to gain robotically steered diagnostic catheter capabilities for its cardiovascular robots. APT is expected to contribute around $5 million in sales in the first year post-acquisition.